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Summary
The SCA7 mutation has been found in 54 patients and
7 at-risk subjects from 17 families who have autosomal
dominant cerebellar ataxia (ADCA) II with progressive
pigmentary maculopathy. In one isolated case, haplotype
reconstruction through three generations confirmed a de
novo mutation owing to paternal meiotic instability. Dif-
ferent disease-associated haplotypes segregated among
the SCA7-positive kindreds, which indicated a multiple
origin of the mutation. One family with the clinical phe-
notype of ADCA type II did not have the CAG expansion
that indicated locus heterogeneity. The distribution of
the repeat size in 944 independent normal chromosomes
from controls, unaffected at-risk subjects, and one af-
fected individual fell into two ranges. The majority of
the alleles were in the first range of 7–19 CAG repeats.
A second range could be identified with 28–35 repeats,
and we provide evidence that these repeats represent
intermediate alleles that are prone to further expansion.
The repeat size of the pathological allele, the widest re-
ported for all CAG-repeat disorders, ranged from 37 to
∼220. The repeat size showed significant negative cor-
relation with both age at onset and age at death. Analysis
of the clinical features in the patients with SCA7 con-
firmed that the most frequently associated features are
pigmentary maculopathy, pyramidal tract involvement,
and slow saccades. The subjects with !49 repeats tended
to have a less complicated neurological phenotype and
a longer disease duration, whereas the converse applied
to subjects with 49 repeats. The degree of instability
during meiotic transmission was greater than in all other
CAG-repeat disorders and was particularly striking in
paternal transmission, in which a median increase in
repeat size of 6 and an interquartile range of 12 were
observed, versus a median increase of 3 and interquartile
range of 3.5 in maternal transmission.
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Introduction
Autosomal dominant cerebellar ataxias (ADCAs) con-
stitute a group of neurodegenerative disorders that can
be classified on clinical grounds into three major cate-
gories (Harding 1993). In ADCA type I, cerebellar ataxia
is variably associated with other neurological features,
including involvement of the central and/or peripheral
nervous system. Four genes have been identified via mo-
lecular studies—SCA1 (MIM 164400), SCA2 (MIM
183090), SCA3 (MIM 109150), and SCA4 (MIM
600223)—on chromosomes 6, 12, 14, and 16, respec-
tively (Orr et al. 1993; Kawaguchi et al. 1994; Flanigan
et al. 1996; Imbert et al. 1996; Pulst et al. 1996; Sanpei
et al. 1996). Although there are some group differences
between phenotypes, as highlighted by Burke et al.
(1997) and Giunti et al. (1998), it is difficult to make a
definitive clinical diagnosis in a single patient, and ge-
netic testing is required. ADCA type III is characterized
by a pure cerebellar syndrome, is genetically heteroge-
neous, and includes SCA5 (MIM 600224) on chromo-
some 11 (Ranum et al. 1994) and SCA6 (MIM 183086)
on chromosome 19 (Zhuchenko et al. 1997).
ADCA type II is distinguished clinically by the pres-
ence of a pigmentary maculopathy (Harding 1982,
1993) and by the variability in the mode of presentation
and striking anticipation (Enevoldson et al. 1994; Be-
nomar et al. 1994, 1995; David et al. 1996). ADCA type
II has been linked to the SCA7 (MIM 164500) locus on
chromosome 3p in all previous reports of families with
this phenotype (Benomar et al. 1994; Gouw et al. 1995;
Holmberg et al. 1995; David et al. 1996; Jo¨bsis et al.
1997). It has hitherto been thought to be genetically
homogeneous. The SCA7 gene has recently been iden-
tified (David et al. 1997; Del Favero et al. 1998; Koob
et al. 1998), and the mutation has been confirmed to be
a CAG expansion in the coding region similar to that
in seven other diseases: spinal-bulbar muscular atrophy
(SBMA), Huntington disease (HD), dentatorubropal-
lidoluysian atrophy (DRPLA), and spinocerebellar
ataxia (SCA) 1, 2, 3 (Machado-Joseph disease), and 6.
Here we analyze the SCA7 gene in 7 families with ADCA
type I, 18 families with ADCA type II, 26 families with
ADCA type III, 56 patients with idiopathic late-onset
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cerebellar ataxia (ILOCA), and 1 subject with early-on-
set idiopathic cerebellar ataxia and maculopathy with-
out a family history.
Material and Methods
Family Data
Eighteen families with ADCA type II who had been
classified according to the criteria suggested by Ene-
voldson et al. (1994) were analyzed for the SCA7 mu-
tation. These families have different ethnic origins: 1
Brazilian, 1 Italian, 1 Indian, 1 Filipino, 1 South African,
and 13 British. Seven families with ADCA type I, 26
families with ADCA type III, 56 patients with ILOCA,
and 1 patient with early-onset maculopathy and cere-
bellar ataxia were also screened. It was confirmed that
no patient had the SCA1, SCA2, SCA3, or SCA6
mutation.
Genotyping
DNA was extracted from lymphocytes by standard
methods. The SCA7 mutation was identified by use of
PCR with oligonucleotide primers 4.1–1,024 (fluores-
cently labeled) and 4.1–716 (David et al. 1997).
PCR was performed in a final volume of 50 ml con-
taining 100 ng of DNA in 1.5 mM MgCl2, 60 mM KCl,
200 mM of each dNTP, 10% of dimethyl sulfoxide, 12
pmol of each primer, and 1.25 U of Taq polymerase.
After an initial denaturation at 95C for 5 min, dena-
turation, annealing, and extension were done at 94C
for 30 s, 55C for 30 s, and 72C for 30 s for 27 cycles
and one final extension for 2 min. The PCR products
were checked on 3.2% agarose gels before analysis on
an ABI 373 and 377 DNA sequencer by means of
GENESCAN software (ABI).
Haplotype reconstruction was possible in 11 families
by use of six microsatellite markers flanking the SCA7
gene and spanning 8 cM (David et al. 1996; Kro¨ls
et al. 1997): D3S3566–3698-1600- (CAG)n-1287-3635-
3644. Microsatellite markers were amplified and ana-
lyzed as described elsewhere by use of the same allele
numbering (David et al. 1996).
For statistical analysis, means were compared with
Student’s t test or F test for mean distribution. Results
are mean SD, unless otherwise indicated. Correlation
analysis was done for CAG-repeat number with age at
onset, age at death, and disease duration.
Results
The analysis of the SCA7CAG expansion showed that
17 of 18 families with ADCA type II carried the novel
triplet mutation, but none of the 7 families with ADCA
type I, 26 families with ADCA type III, or 56 subjects
with ILOCA carried it. We identified a de novo mutation
in a subject with no family history who presented with
maculopathy at age 14 years (family VN, fig. 1).
Distribution of Normal, Intermediate, and Pathological
Alleles
The distribution of the SCA7 CAG repeats in our se-
ries of 944 independent chromosomes from randomcon-
trols, from spouses of family members with ADCA type
II, and the normal chromosomes from affected subjects
is shown in figure 2. Two distinct allele ranges are evi-
dent. The first, 7–19 repeats, contains the majority of
the alleles found in normal controls and unaffected at-
risk subjects. The most common allele, with 10 repeats,
accounted for 72% of these normal alleles and was
found in a homozygous state in 55% of normal controls,
in agreement with a previous report (David et al. 1998).
Alleles in the second range of 28–35 CAG repeats were
found in one affected individual (genotype 29/53 re-
peats), in seven unaffected at-risk relatives, and in one
spouse from a total of three families. These at-risk sub-
jects, whose mean age was years (range,58.3 17.4
39–85), shared the same haplotype with their affected
relatives. Therefore, we propose that this group repre-
sents intermediate alleles with a propensity for patho-
logical expansion, as is clearly shown in family VN (fig.
1) (Stevanin et al. 1998), whereas the first group, with
alleles in the range of 7–19 repeats, represents the true
normal range. Repeat-size distribution for 55 affected
subjects and the 7 at-risk carriers is shown in figure 3.
These pathological alleles had a range of 37 to ∼220
repeats (median, 48; interquartile range, 7.75), the larg-
est of which were 180 and ∼220 repeats and were trans-
mitted by affected fathers with 39 and 54 repeats,
respectively.
Alleles with such a large number of CAG repeats have
not been reported in other CAG-repeat diseases (SBMA,
HD, DRPLA, SCA 1, SCA 2, or SCA 3).
There was no significant difference in the distribution
of the expanded repeats between male ( ) and fe-n  32
male ( ) subjects.n  30
Correlation with the Number of CAG Repeats and
Clinical Parameters
There was a significant inverse correlation with the
age at onset of 45 patients and the number of CAG
repeats ( ; ), as shown in figure 4. Wer  0.74 P ! .0001
did not include in the linear regression analysis the two
large alleles of 180 and 220 repeats with age at onset
of 2 years and 1 year, respectively, since these skewed
the slope of the line disproportionately. Statistical sig-
nificance was also found when the age at onset of the
maculopathy and the age at onset of the ataxia were
correlated independently with the size of the repeat
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Figure 1 Pedigrees of VN, PT, and WI families. Solid symbols denote affected status. The pedigrees have been altered by changing birth
order and by substituting diamond symbols for some individuals of both sexes. Haplotypes for chromosome 3p markers are shown. Boxed
haplotypes cosegregate with the expanded and intermediate CAG repeats. Boldface numerals denote number of CAG repeats. Dashes are used
when alleles could not be typed or deduced.
( and , respectively). Age at deathP  .0006 P ! .0001
and disease duration at death in eight patients also
showed highly significant inverse correlation with CAG-
repeat size ( and , respectively).P  .0064 P  .004
Sex of the Transmitting Parent
The change in size of the pathological allele in 31
parent–child transmissions is shown in figure 5. The
overall median was 4 and interquartile range was 9 in
31 parent-child pairs, whereas the median and inter-
quartile range were 6 and 12 in 17 father-child pairs
versus 3 and 3.5 in 14 mother-child pairs, respectively.
This difference was statistically significant (F test, P !
). Increases in size 110 repeats, although less com-.0001
mon, occurred more frequently during paternal
transmissions.
There was no difference in the mean repeat number
between alleles that underwent expansion during trans-
mission by 10 ( ; ) and 110 repeats44 6.1 n  23
( ; ).43.4 5.5 n  8
In family VN, an intermediate allele with 35 repeats
was stable during maternal transmission but underwent
pathological expansion to 57 repeats when transmitted
by the unaffected father. In contrast, in the WI pedigree,
only mild instability of the intermediate allele was ob-
served, with 29 repeats in the unaffected father and 30
repeats in one of his unaffected offspring. Haplotype
reconstruction confirmed the parental origin of these
repeats.
Clinical Features of Subjects with an Intermediate
Allele
When subjects II-1 and II-2 in family PT, both with
28 repeats (fig. 1), were examined, neither ataxia nor
maculopathy was found. In family VN, a 57-year-old
subject (II-1) and a 39-year-old subject (III-1), both with
intermediate alleles of 35 repeats, underwent extensive
ophthalmologic examination, including Ishihara plates,
blue-yellow plates, fluorescein angiography of the retina,
and ERG, the results of which were normal. An 85-year-
old relative (I-4) with the same number of CAG repeats
had nonprogressive visual impairment but no other neu-
rological signs. The ophthalmologic examination iden-
tified a maculopathy that could not be distinguished
from senile maculopathy, a finding quite common in eld-
erly subjects. Moreover, in our experience, patients who
have SCA7with 49 repeats present with cerebellar ataxia
and dysarthria rather than maculopathy, but we cannot
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Figure 2 Distribution of CAG-repeat numbers in 1,054 inde-
pendent normal chromosomes from control subjects, spouses, and af-
fected subjects. Two ranges are evident: the first, 7–19, represents the
true normal range, and the second, 28–35, represents intermediate
alleles (see text).
exclude the possibility that the maculopathy was a very
late presenting sign of a SCA7 phenotype.
The WI family comes from Jamaica, and, although
the parents are of different ethnic origins (Indian and
Afro-Caribbean), they share the same disease-associated
haplotype. The father has 29 repeats and is still unaf-
fected at the age of 65 years.
Clinical Features of Patients with ADCA Type II
For 47 subjects, the median age at onset was 32 years
(range, 1–76). The median age at death and disease du-
ration at death in 8 patients were 48.5 years (range,
3–82) and 20.5 years (range, 2–28), respectively. Disease
duration leading to an inability to walk was 10.9 years
(range, 3–21) ( ).n  25
For 36 of the SCA7-positive patients from 13 families,
it was possible to obtain detailed clinical information.
The mean time interval in 32 patients between age at
onset of ataxia and age at onset of maculopathy, or vice
versa, was years (range, 0–22). There was a4.3 11.6
time interval of 10 years between these two presenting
features in 6 patients, 3 of whom presented with ma-
culopathy at a mean age of years; the other32.6 11.1
3 patients presented with ataxia at a mean age of
years.44.3 14.7
The median disease duration (age at examination mi-
nus age at onset) was 15.3 years in 21 subjects with !49
repeats and 10.9 years in 15 patients with 49 repeats.
This difference was statistically significant ( ).P  .02
The length of the CAG-repeat expansion also appeared
to influence the mode of presentation. In 19 subjects in
whom the onset of maculopathy preceded the onset of
ataxia, the mean number of repeats on the pathological
allele was significantly more at , compared53.5 6.8
with repeats in 15 subjects in whom ataxia45.6 3.7
was the presenting clinical feature ( ). In 11P  .0003
patients in whom the presentation of ataxia and ma-
culopathy were coincident, the mean number of repeats
was . The two subjects with very long repeats48 5.5
(180 and 220) were not included in this analysis, because
the clinical information was insufficient to assign the
sign(s) at onset. The sex of the transmitting parent did
not influence the presenting feature of the disease (data
not shown).
Table 1 compares the clinical features, separated ac-
cording to repeat size, of 36 patients from 13 SCA7
expansion–positive families with those of the 3 patients
belonging to the family clinically assessed as ADCA type
II but lacking an abnormal SCA7 expansion. At the time
of examination, all the SCA7-positive patients showed
cerebellar ataxia, whereas maculopathy was identified
in 32 of 36 patients. Pyramidal signs with hyperreflexia
were present in 33 patients. Nuclear ophthalmoplegia
was present in 11 patients, 10 of whom were from the
same Brazilian family; supranuclear ophthalmoplegia
was present in 25 patients and slow saccades in 20 pa-
tients. Subjects with 49 repeats had a more compli-
cated disease phenotype.
The phenotype of the SCA7-negative family did not
show striking differences from that of the 13 SCA7-
positive families. The median age at onset and disease
duration were similar in both SCA7-positive and -neg-
ative patients. All three patients had both ataxia and
maculopathy, and there was evidence of involvement of
the pyramidal system with hyperreflexia, extensor plan-
tar reflexes, and/or spasticity. None of the SCA7-nega-
tive patients showed ophthalmoplegia or slow saccades.
Overall, lower motor neuron signs and extrapyram-
idal signs, as detailed in table 1, were associated with a
higher number of repeats, as were sphincter disturbance
and sensory loss.The neuroimaging of eight SCA7-pos-
itive and two SCA7-negative patients showed cerebellar
atrophy and a variable degree of brain-stem atrophy.
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Figure 4 Correlation between the number of SCA7CAG repeats
and age at onset in years. The linear regression line has been applied
without including the two largest alleles, as these skew the slope
disproportionately.
Figure 3 Distribution of repeat numbers of 55 chromosomes from patients and 7 from at-risk subjects
Reconstruction of Haplotypes Segregating with the
Disease; Evidence for Multiple Founders
Three different disease-associated haplotypeswere ob-
served among five British families and one North Amer-
ican family with markers D3S1600 and D3S1287 (table
2), which flank the SCA7 gene (Del Favero et al. 1998).
This probably reflects the multiple origin of the SCA7
mutation in this Anglo-Saxon population. In five of six
of these kindreds, allele 4 of D3S1287 segregated with
the pathological allele.
The South African and Indian haplotypes were dif-
ferent from those in the British families, suggesting that
different founder mutations are likely to have occurred.
Furthermore, the two Italian kindreds from the same
area in central Italy had haplotypes that were divergent
telomeric and centromeric to the SCA7 locus except for
allele 3 of D3S1287, although this allele is frequent in
European controls (0.42%). These data again suggest
the possibility of multiple founders.
Discussion
These data have shown that an expanded CAG repeat
within the SCA7 gene segregated with the disease in 17
of 18 families with a clinical diagnosis of ADCA type
II and in one patient with no family history of the
disease.
There was a significant inverse correlation between
the age at onset and the number of CAG repeats, which
was still observed when the age at onset of ataxia or
maculopathy was correlated independently. We did not
include the two largest alleles of 180 and ∼220 repeats
in the correlation analysis, because of the small numbers
of these rare large alleles. However, an exponential plot
to fit these additional data resulted in an r value of 0.9
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Figure 5 Difference in CAG-repeat instability between 14 mother-child pairs and 17 father-child pairs. Only positive values, representing
an increase in CAG repeats during transmission, are shown for both sexes. The largest increases occur during paternal transmission.
( ). There was also a significant correlationwithP ! .0001
age at death and disease duration until death. Therefore,
higher numbers of CAG repeats are associated with an
earlier age at onset and a more rapid progression of the
disease, leading to an early death.
ADCA type II has a variable phenotype. Patients with
!49 CAG repeats tend to have a rather pure cerebellar
ataxia for many years and a more benign progression
of the disease. In contrast, patients with 49 repeats
tend to show a phenotype characterized by cerebellar
ataxia complicated with other neurological signs, with
a shorter disease duration. Macular degeneration re-
mains the most common of the associated clinical fea-
tures and was present in 32 of our 36 patients. The
absence of the SCA7 expansion in our 7 families with
ADCA I and 26 families with ADCA III confirmed this
clinical exclusivity.
The comparison of our clinical results with those of
others (David et al. 1998; Johansson et al. 1998) showed
no substantial differences. Hypoacusis was a frequent
associated symptom in the patients with SCA 7 reported
by David et al. (1998) but was not found in our patients
or in the patients reported by Johansson et al. (1998).
David et al. 1998 did not report whether hypoacusis
was present in patients belonging to a single family or
was found in unrelated affected subjects. This sign may
be a variable associated symptom, analogous to the pres-
ence of dementia in only some families with SCA 2, and
may not be influenced by the number of CAG repeats
(Scho¨ls et al. 1997; Giunti et al. 1998).
The range of normal SCA7 alleles was 7–19 in 939
independent chromosomes, and we identified an inter-
mediate range of 28–35 repeats among seven asymp-
tomatic relatives and one affected individual in three
families with SCA 7. Evidence for multiple founders was
observed after haplotype reconstruction.
The smallest pathological alleles had 37 repeats, sim-
ilar to the number of repeats found in affected subjects
with SBMA (37), HD (35), SCA 1 (42), and SCA 2 (33).
All these diseases share a common feature in that only
a few repeats define the difference between normal and
pathological alleles. Rubinsztein et al. (1996) found that
some subjects with HD who have an intermediate num-
ber of CAG repeats (i.e., 36–39) may be unaffected at
a late age, whereas others with 36 CAG repeats are
affected. This study concluded that incomplete pene-
trance occurred in HD, contrary to previous clinical ob-
servations. Although ADCA type II is a rarer condition,
incomplete penetrance has been suggested on the basis
of pedigree analysis (Enevoldson et al. 1994; Benomar
et al. 1995; David et al. 1996; Kro¨ls et al. 1997). This
might be explained by these intermediate alleles that are
not in themselves pathological but can be unstable dur-
ing transmissions and give rise to new mutations.
The high degree of meiotic instability that we ob-
served, along with the finding of the SCA7 mutation in
a patient with the typical phenotype of ADCA type II
but with no family history, raised the possibility of fre-
quent de novo mutations, perhaps caused by the expan-
sion of an intermediate allele. This prompted us to screen
56 patients with ILOCA for the SCA7 mutation, and all
were negative. ADCA type II was linked to the short
arm of chromosome 3 in all previously reported families
despite different ethnic origins, suggesting genetic ho-
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Table 1
Clinical Features of ADCA Type II Patients, Divided According to Repeat Number and Presence of





( )n  3
!49 Repeats
( )n  20
49 Repeats
( )n  16
All
( )n  36
Median age at onset (range) [years]:
Ataxia 40.5 (19–72) 22 (1–54) 32.5 (1–72) 47 (30–53)
Maculopathy 37 (17–73) 19 (1–56) 32.5 (1–73) 53 (14–54)
Median disease duration (range) [years] 11 (2–29) 9.5 (2–23) 7 (2–29) 7 (5–19)
Mean interval between onset of ataxia
and of maculopathy, or vice versa
(range) [years] 5.9 (0–22) 3.8 (0–17) 4.8 (0–22) 7 (0–16)
Cerebellar ataxiaa 20 (100) 16 (100) 36 (100) 3
Maculopathy 16 (80) 16 (100) 32 (89) 3
Supranuclear ophthalmoplegia 14 (70) 11 (69) 25 (69) 0
Nuclear ophthalmoplegia 3 (15) 8 (50) 11 (31) 0
Staring gaze 0 (0) 1 (6) 1 (3) 0
Slow saccades 11 (55) 9 (56) 20 (55) 0
Optic atrophy 0 (0) 3 (19) 3 (9) 0
Dysphagia 8 (40) 12 (75) 20 (55) 1
Dysarthria 20 (100) 16 (100) 36 (100) 3
Extrapyramidal featuresb: 0 (0) 4 (25) 4 (11) 0
Facial dystonia 0 (0) 1 (6) 1 (3) 0
Dystonia in arms or legs 0 (0) 2 (13) 2 (6) 0
Chorea 0 (0) 2 (13) 2 (6) 0
Rigidity 0 (0) 2 (13) 2 (6) 0
Bradykinesia 0 (0) 0 (0) 0 (0) 0
Hypomimia 0 (0) 1 (6) 1 (3) 0
Fasciculations of face, tongue, or limbs 3 (15) 6 (38) 9 (25) 0
Increased reflexes 18 (90) 15 (94) 33 (92) 2
Babinski 4 (20) 7 (44) 11 (31) 1
Sensory loss 0 (0) 1 (6) 1 (3) 0
Dementia 0 (0) 0 (0) 0 (0) 0
a Values are number (%) of patients except for SCA7-negative patients, for whom only numbers are
given.
b Total numbers of patients with extrapyramidal features are given, but some patients had more than
one extrapyramidal sign.
mogeneity (Benomar et al. 1995; Gouw et al. 1995; Da-
vid et al. 1996; Holmberg et al. 1995; Jo¨bsis et al. 1997).
Additional evidence came from pathological and clinical
classifications, which have distinguished this disease as
a separate entity since its first description by Froment et
al. (1937). Here we report the first family with ADCA
type II without a pathological expansion at the SCA7
locus. To exclude an error in sample handling, we ob-
tained repeat samples from the affected members of the
family.
No striking difference between the phenotypes of the
SCA7-positive and SCA7-negative patients was ob-
served, although no statistical analysis could be per-
formed because of the small sample number of the latter
group. However, neither ophthalmoplegia nor slow sac-
cades was observed in any of the three SCA7-negative
subjects, despite evidence of brain-stem atrophy on the
computed tomographic scan in two subjects. Although
an allelic disorder is a possibility, this has been reported
in only one other CAG-repeat disease, in which point
mutations in sites on the SCA6 gene independent of the
CAG-repeat domain can lead to episodic ataxia type 2
or familial hemiplegic migraine (Jodice et al. 1997;
Ophoff et al. 1997). However, haplotype analysis dem-
onstrates no common alleles among the affected subjects
of the expansion-negative family at the SCA7 locus (data
not shown), and we may therefore exclude this hypoth-
esis. We conclude that ADCA type II is genetically het-
erogeneous, in common with ADCA type I and ADCA
type III.
We provide evidence that a reservoir of intermediate
alleles has a tendency to undergo pathological expan-
sion, particularly in paternal transmission (fig. 1). In
family PT, the haplotype segregating with the patholog-
ical expansion is the same as that reconstructed in the
two members with 28 repeats, II-1 and II-2. This hap-
lotype was derived from the father, who died at the age
of 75 years without showing either cerebellar ataxia or
impairment of vision. Since DNA from this individual
was not available, we cannot exclude homozygosity for
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Table 2
Haplotypes Segregating in 11 SCA7 Families in Which Haplotype Reconstruction Was Possible
Origin D3S3566 D3S3698 D3S1600 SCA7 D3S1287 D3S3635 D3S3644
India 5 7 11 11 1 6
South Africa 2 6 13 2/10 3 3
United States 4 7/8 13/5 4 6 6
United Kingdom 4 7 5 4 6 6
United Kingdom 4 7 5 4 6 6
United Kingdom 4 7 5 4 6/4 6
United Kingdom 4 6 13 4 6 2
United Kingdom 4 6 13 3/4 6 3/6
Italy 4 8 10 3 6 3
Italy 3 7 5 3 4 2
Philippines 1/3 6 5/13 3 4 6
the six markers spanning the 8 cM in the SCA7 region.
However, the absence of 19 repeats in 939 independent
normal chromosomes in this study and in other reports
(David et al. 1998; Del Favero et al. 1998; Johansson
et al. 1998) makes the hypothesis of two intermediate
alleles undergoing expansion unlikely. A similar event
occurred in the family VN; in the first generation, two
relatives had the same haplotype, segregating with 30
and 35 repeats, respectively. In this case, we were unable
to identify the sex of the transmitting carrier. Both par-
ents died in their 80s without signs of the disease. During
maternal transmission, no change in the number of CAG
repeats was seen. However, the couple’s son (II-1) trans-
mitted an unchanged allele to one offspring and a 22-
repeat increase in the expansion (from 35 to 57) to the
other child, leading to disease onset at the age of 14
years in the latter (fig. 1).
David et al. (1998) showed that the gonadal mosai-
cism in SCA 7 is strikingly greater than in blood with
respect to other CAG-repeat diseases. This finding could
explain not only the marked anticipation but also the
great variability in age at onset in siblings. This com-
plicates genetic counseling for presymptomatic and pre-
natal testing, especially in male transmissions.
The SCA7 mutation has the widest range of CAG
repeats (from 37 to 220) reported to date in comparison
with all the other CAG disorders, in which alleles with
90 repeats are uncommon (Sathasivam et al. 1997). The
differences in the normal and disease-causing ranges
among these differing disorders must lie, in part, in the
ability of the rest of the protein to “tolerate” these var-
iable polyglutamine lengths.
Greater paternal instability during transmission is a
common finding in HD, SCA 1, SCA 2, SCA 3, and
DRPLA. The present data show the greatest consistent
increase in repeat size during meiosis thus far reported,
with a mean increase of 23.9 repeats during paternal
transmissions versus a mean of 4 repeats duringmaternal
transmission. A modest decrease of two CAG repeats
has been reported in one Swedish family (Johansson et
al. 1998). It may be that the instability is associated with
a specific intragenic polymorphism similar to that seen
in SCA 3 (Takiyama et al. 1997), for which meiotic
segregation distortion in favor of the expanded alleles
has been proposed (Ikeuchi et al. 1996).
In summary, this study showed that the majority of
families with ADCA type II and one affected subjectwith
no family history had the SCA7 expansion. Haplotype
reconstruction highlights that different ancestral muta-
tions are involved among families with SCA 7. The num-
ber of CAG repeats influences the phenotype by affecting
age at onset, disease duration, and the presenting feature.
The SCA7mutation shows a greater instability than that
in other CAG-repeat diseases, which may result in strik-
ing anticipation. Affected children may die before re-
production, and the finding of de novo expansion is in
keeping with the perpetuation of this disease. Specific
intragenic polymorphism may play a role in determining
meiotic instability.
Genetic diagnosis will increase the possibility to define
a diagnosis in patients without a family history. The
small gap, only a 2-repeat difference, between inter-
mediate alleles and the pathological allele is similar to
that found in HD. We therefore suggest that genetic
counseling of subjects at risk for SCA 7 should follow
the same guidelines as those for HD.
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